Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of low molecular weight heparins during hemodialysis
2008-005224-91Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of low molecular weight heparin calcium in chronic kidney disease (CKD), sponsored by Ghent University Hospital. Primary endpoint: Extracorporeal clearance of small uremic retention solutes at start and during hemodialysis. Started Aug 2008; status: completed.
02
Drugs
low molecular weight heparin calcium
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2008-005224-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005224-91.